Form D/A — Renibus Therapeutics, Inc.
0001667699-25-000002 · filed Jul 17, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $110,895,239
- Reported amount sold
- $110,895,239
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Renibus Therapeutics, Inc.
- CIK
- 1667699
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 181 GRAND AVE., SUITE 225
SOUTHLAKE, TX 76092 - Phone
- 386-527-1071
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Carlos Guillem · DirectorSouthlake, TX Find on LinkedIn ↗
-
D. Jeffrey Keyser · Executive OfficerSouthlake, TX Find on LinkedIn ↗
-
Henrik Rasmussen · DirectorSouthlake, TX Find on LinkedIn ↗
-
Bhupinder Singh · Executive OfficerSouthlake, TX Find on LinkedIn ↗
-
Jamie Donadio · Executive OfficerSouthlake, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗